Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 3 recruiting now full pipeline small index

PCOS: full-pipeline trial registry

3 of 9 indexed PCOS trials are currently recruiting.

Corpus placement: #1,916 of 28,707 conditions by registered trial count.

9 US clinical trials · 3 currently recruiting · #1,916 of 28,707 conditions by registered trial count

PCOS: 9 US clinical trials tracked, 3 recruiting.

PCOS is the subject of 9 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is University of California, San Francisco, running 2 of these trials.

Enrollment posture brief

Registry condition pcos

OPEN 3 | RECR 33% | LATE 2 | EARLY 3 | RANK #1916 | SPON 2

Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)

Acute Lymphoblastic Leukemia55.6%Acute Respiratory Distress S55.6%PCOS (this)33%Acute Otitis Media22.2%Acute Heart Failure11.1%
Open-enrollment share among volume-matched conditions near PCOS

PCOS lists 3 open slots (33% of 9 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for PCOS on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. PCOS is recruiting below its size-band peers.

    3 of 9 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates PCOS research.

    University of California, San Francisco accounts for 2 of 9 trials (22.2%). 8 distinct sponsors appear on at least one study for this condition label.

  3. Most PCOS trials plan to enrol fewer than 100 people.

    Median target enrolment is 50 among the 9 trials that report a genuine target (sentinel values excluded). 6 of those (66.7%) plan for fewer than 100 participants.

  4. PCOS research is mostly interventional.

    7 interventional and 2 observational studies make up this index (77.8% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11Phase 22Phase 31Phase 41

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 2 2
Phase 3 1
Phase 4 1

Named interventions

Most-linked intervention names on PCOS records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Metformin and Spironolactone Drug
1 trials
Weight loss diet Other
1 trials
Semaglutide 3mg and 7mg [Rybelsus] Drug
1 trials
recombinant human chorionic gonadotropin (r-hCG) Drug
1 trials
diazoxide Drug
1 trials
Oral glucose tolerance test Other
1 trials
Adipose tissue biopsy Procedure
1 trials
MR assessment of Whole Body Fat Other
1 trials

US sites by state

Facility locations filed on PCOS trials. A trial with sites in several states counts in each.

California 3 trials
Colorado 2 trials
Wisconsin 1 trials
Virginia 1 trials
North Carolina 1 trials
Missouri 1 trials
Iowa 1 trials
Florida 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this PCOS page

9 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This PCOS condition card totals 9 registered trials; most-linked intervention Metformin and Spironolactone; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.